-The Pioneer In the absence of any sunset clause or distinct feature to identify the beneficiaries who succeed in climbing themselves out of poverty, the scheme of direct cash transfer as an income support welfare measure and as a potent tool of empowerment does not sound convincing even on paper Thanks to the proposal for the universal basic income, it has become a topic for discussion as one-fifth population of this country...

-The Hindu CDSCO sends letter to manufacturers Alerted by the Union Health Ministry’s pharmaceutical watchdog, the National Co-ordination Centre of the Pharmacovigilance Programme of India (PvPI), on adverse reactions that were being reported from some commonly-used antibiotics, the Central Drugs Standard Control Organisation (CDSCO) has now asked manufacturers to ensure that this information be made available to the general public. CDSCO has written to drug manufacturers, to mention in leaflets inserted into drug...

-OutlookIndia.com While implementing the Mid Day Meal Scheme, there should be no difference on the issue of whether the child is in a government school or not. The Odisha government has launched several schemes, like the Millets Mission and Iron Plus Initiative, to boost nutrition among the people, especially children and the tribal population, and the state must work to ensure that none is left out from the Poshan Abhiyaan, an...

-The Economic Times A campaign called 'Bridge the Care Gap' has been lobbying political parties to commit to the implementation of the Mental Healthcare Act and the National Mental Health Policy On April 2, Rahul Gandhi, Sonia Gandhi, and other senior Congress leaders unveiled the party's manifesto for the Lok Sabha elections. The Congress website crashed with a huge spike in traffic. Most analyses of the manifesto focused on the usual themes...

-The Times of India NEW DELHI: In what is being seen as an attempt to delay launch of low priced generic medicines, multinational drug makers have asked the government to create a registry providing information about all drug applications pending manufacturing and marketing approval. The proposal, if accepted by the government, will help ‘big pharma’ pre-emptively challenge generic drug makers in court for allegedly infringing upon their patents and in turn blocking...